Overview

Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic

Status:
RECRUITING
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The goal of this study is to test the efficacy of Dupixent in improving post-burn itching symptoms versus the current standard of care.
Phase:
PHASE2
Details
Lead Sponsor:
Akron Children's Hospital
Collaborators:
Ohio State University
Regeneron Pharmaceuticals
Treatments:
dupilumab